RxDoctor Payments Data

Robert Brummeler, MD

Family Medicine · Swartz Creek, MINPI 1831205806

Payments from drug & device makers

$5,118in general payments, 2019–2025

Across 352 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$980
  • Otsuka America Pharmaceutical, Inc.$373
  • AstraZeneca$348
  • Amgen$285
  • Axsome Therapeutics, Inc.$242
  • Jazz Pharmaceuticals Inc.$235
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$5,118100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,118 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$111,839
Medicare patients
157
Services billed
1,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban137$105,783
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69$51,944
VraylarCariprazine Hcl16$33,694
RexultiBrexpiprazole20$28,240
JardianceEmpagliflozin26$27,471
OzempicSemaglutide29$26,056
TrulicityDulaglutide17$22,632
XareltoRivaroxaban18$20,933
EntrestoSacubitril/Valsartan17$20,649
MyrbetriqMirabegron17$18,758
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl76$15,922
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$11,392
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen768$11,119
Albuterol Sulfate HfaAlbuterol Sulfate215$10,088
JanuviaSitagliptin Phosphate11$9,127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$140$105,783137 claims
GSKTrelegy Ellipta$65$51,94469 claims
AbbVieVraylar$980$33,69416 claims
Otsuka America Pharmaceutical, Inc.Rexulti$373$28,24020 claims
Boehringer IngelheimJardiance$25$27,47126 claims
Novo NordiskOzempic$202$26,05629 claims
Lilly USA, LLCTrulicity$104$22,63217 claims
Johnson & JohnsonXarelto$17$20,93318 claims
NovartisEntresto$105$20,64917 claims
Astellas Pharma US IncMyrbetriq$77$18,75817 claims
AstraZenecaBreztri Aerosphere$348$11,39213 claims
MerckJanuvia$72$9,12711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Swartz Creek

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →